Join Us At The 33rd Virtual ECP 2021 Congress

Join us virtually at the 33rd European Congress of Pathology (ECP) to discuss how to accelerate the adoption of precision oncology in your laboratory. Come and experience why next generation sequencing is the platform of choice for tumour genomic profiling and how you can now do NGS in 1 day with the speed and simplicity of immunohistochemistry.

This year we will have the opportunity to network with you during two exciting symposia. See details below.

Join us at ECP 2021
and network with our speakers

Come to our symposia to hear about our speakers’ experiences in delivering NGS genomic profiles in 1 day with the speed and simplicity of immunohistochemistry and how they have maximised their oncology biomarkers testing strategies to analyse current and emerging biomarkers.

Current and emerging oncology biomarkers testing strategies

Monday, 30th August 2021, 11:45 – 13:15 CEST

In this seminar thought leaders will share their experience in delivering NGS genomic profiles in 1 day with the speed and simplicity of immunohistochemistry and how they have maximised their oncology biomarkers testing strategies to analyse current and
emerging biomarkers.

mossimo

Chair
(5 minutes)

Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Milan, Italy

Sherlock

The future of precision oncology with 1 day NGS
(15 minutes)

Dr. Jon Sherlock, Director Product Management, Thermo Fisher Scientific

 

javier

The economic advantage of
in-house 1 day NGS
(20 minutes)

Dr. Javier Hernandez Losa, ‎Director of Molecular Biology Laboratory, Pathology Department, ‎Vall d'Hebron University Hospital, Barcelona, Spain

Normanno

The role of comprehensive genomic profiling in emerging biomarker testing (20 minutes)

Dr. Nicola Normanno, Director of Department of Experimental Oncology, INT-Fondazione Pascale, Naples, Italy

Wild

Algorithms to use different sizes of panels for different types of cancers - experience in a molecular pathology lab (20 minutes)

Prof. Dr. Peter Wild, Director of Dr. Senckenberg Institute for Pathology, University Hospital Frankfurt, Frankfurt, Germany

Comprehensive genomic profiling in precision oncology

Tuesday, 31st August 2021, 6:45 – 7:45 CEST

In this symposium, we will hear about the experience of different laboratories and the strategy they are employing for different biomarker types and clinical research projects.

Jose

Introduction to multi-biomarker profiling: what is the data saying about it? (10 minutes)

Dr. Jose Luis Costa, EMEA Medical Affairs Director, Thermo Fisher Scientific

 

 

Alborelli

Comprehensive genomic profiling with the Oncomine Comprehensive Assay Plus (20 minutes)

Ilaria Alborelli, PhD,
Clinical Data Analyst, Institute of Pathology and Medical Genetics, University Hospital Basel, Switzerland

mossimo

Multicentric study to evaluate in-house solution for CGP
(20 minutes)

Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Milan, Italy

 

Register for Live Event

To register for the live ECP Virtual 2021 event or view the full agenda, click the button below.


register-now-cta

 

Learn More

It's NGS, as fast and easy As IHC or PCR

The Oncomine Precision Assay on the Ion Torrent Genexus System features a complete next-generation sequencing (NGS) testing workflow. Now every lab can go from sample to report in a single day, providing a comprehensive genomic profile at a speed never possible before. This allows you to deliver NGS results at the same time as other single-gene methods, such as immunohistochemistry (IHC) and PDL1 biomarker test. The hands-off, set-up-and-go workflow makes NGS accessible, even if your lab is new to the technology.

 

Would you like to speak with a Thermo Fisher Scientific representative?
Click the button below to request contact.

request-contact-cta

 

For Research Use only. Not for use in diagnostic procedures.